Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism

Experimental and Molecular Pathology

Volumn 83, Issue 3, 2007, Pages 361-366

  Rull, Anna ^a   Escolà Gil, Joan Carles ^b   Julve, Josep ^b   Rotllan, Noemí ^b   Calpe Berdiel, Laura ^b   Coll, Blai ^a   Aragonès, Gerard ^a   Marsillach, Judit ^a   Alonso Villaverde, Carlos ^a   Camps, Jordi ^a   Blanco Vaca, Francisco ^b   Joven, Jorge ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Hyperlipidemia; Inflammation; Insulin resistance; LDLr deficiency; MCP 1; Monocyte chemoattractant protein 1; Obesity

Indexed keywords

FATTY ACID; GLUCOSE; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL INTAKE; CONTROLLED STUDY; FAT INTAKE; FEEDING; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HYPERLIPIDEMIA; LIPID METABOLISM; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; OBESITY; PROTEIN DEFICIENCY; PROTEIN FUNCTION;

MUS;

EID: 36048979016     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2007.08.003     Document Type: Article

References (25)

1. Baldeweg S.E., Golay A., Natali A., Balkau B., Del Prato S., and Coppack S.W. Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. Eur. J. Clin. Investig. 30 (2000) 45-52
2. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
3. Chen A., Mumick S., Zhang C., Lamb J., Dai H., Weingarth D., Mudgett J., Chen H., MacNeil D.J., Reitman M.L., and Qian S. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes. Res. 13 (2005) 1311-1320
4. Cushing S.D., Berliner J.A., Valente A.J., Territino M.C., Navab M., Parhami F., Gerrety R., Schwartz C.J., and Fogelman A.M. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 5134-5138
5. Escola-Gil J.C., Julve J., Marzal-Casacuberta A., Ordonez-Llanos J., Gonzalez-Sastre F., and Blanco-Vaca F. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia. J. Lipid Res. 41 (2000) 1328-1338
6. Farese Jr. R.V., Yost T.J., and Eckel R.H. Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism 40 (1991) 214-216
7. Fielding B.A., and Frayn K.N. Lipoprotein lipase and the disposition of dietary fatty acids. Br. J. Nutr. 80 (1998) 495-502 (Review)
8. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., and Rollins B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2 (1998) 275-281
9. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
10. Inouye K.E., Shi H., Howard J.K., Daly C.H., Lord G.M., Rollins B.J., and Flier J.S. Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 56 (2007) 2242-2250
11. Julve J., Robert M.Q., Llobera M., and Peinado-Onsurbe J. Hormonal regulation of lipoprotein lipase activity from 5-day-old rat hepatocytes. Mol. Cell. Endocrinol. 116 (1996) 97-104
12. Julve J., Escola-Gil J.C., Marzal-Casacuberta A., Ordonez-Llanos J., Gonzalez-Sastre F., and Blanco-Vaca F. Increased production of very-low density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet. Biochim. Biophys. Acta 1488 (2000) 233-244
13. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., Ohtsuka-Kowatari N., Kumagai K., Sakamoto K., Kobayashi M., Yamauchi T., Ueki K., Oishi Y., Nishimura S., Manabe I., Hashimoto H., Ohnishi Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Nagai R., and Kadowaki T. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 281 (2006) 26602-26614
14. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., and Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116 (2006) 1494-1505
15. Lewis G.F. Fatty acid regulation of very low density lipoprotein production. Curr. Opin. Lipidol. 8 (1997) 146-153 (Review)
16. Lewis G.F., Carpentier A., Adeli K., and Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23 (2002) 201-229
17. Luster A.D. Chemokines-chemotactic cytokines that mediates inflammation. N. Engl. J. Med. Rev. 338 (1998) 436-445
18. Nelken N.A., Coughlin S.R., Gordon D., and Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88 (1991) 1121-1127
19. Paolisso G., Ferrannini E., Sgambato S., Varricchio M., and D'Onofrio F. Hyperinsulinemia in patients with hypercholesterolemia. J. Clin. Endocrinol. Metab. 75 (1992) 1409-1412
20. Ribas V., Palomer X., Roglans N., Rotllan N., Fievet C., Tailleux A., Julve J., Laguna J.C., Blanco-Vaca F., and Escola-Gil J.C. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate. Biochim. Biophys. Acta 1737 (2005) 130-137
21. Steinberg D., and Lewis A. Conner Memorial Lectura, oxidative modification of LDL and atherogenesis. Circulation 95 (1997) 1062-1071
22. Tous M., Ferre N., Rull A., Marsillach J., Coll B., Alonso-Villaverde C., Camps J., and Joven J. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E deficient mice. Biochem. Biophys. Res. Commun. 340 (2006) 1078-1084
23. Tous M., Ribas V., Escola-Gil J.C., Blanco-Vaca F., Calpe-Berdiel L., Coll B., Ferre N., Alonso-Villaverde C., Rull A., Camps J., and Joven J. Manipulation of inflammation modulates hyperlipidemia in apolipoprotein E-deficient mice: a possible role for interleukin-6. Cytokine 34 (2006) 224-232
24. Vilella E., Joven J., Fernandez M., Vilaro S., Brunzell J.D., Olivecrona T., and Bengtsson-Olivecrona G. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. J. Lipid Res. 34 (1993) 1555-1564
25. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., Charo I., Leibel R.L., and Ferrante Jr. A.W. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116 (2006) 115-124